Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00332124 · ClinicalTrials.gov registry record · Phase 1
Safety and Effectiveness of Taking Choline Supplements During Pregnancy for Improving Infant Brain Development
A Phase 1 study of Pregnancy and Child Development, sponsored by University of Colorado, Denver.
- Completed
- Registry status
- Phase 1
- Development phase
- 351
- Enrollment target
- 1
- Study location
NCT00332124: Completed Phase 1 study of Pregnancy and Child Development, sponsored by University of Colorado, Denver.
NCT00332124 is a Phase 1 study of Pregnancy and Child Development that has completed, run by University of Colorado, Denver. The registered enrollment target is 351 participants, below the 871-participant average among 191 other Pregnancy trials with a reported enrollment target (60% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00332124, a Phase 1 study of Pregnancy and Child Development, has completed, sponsored by University of Colorado, Denver.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 351 participants
- Enrollment target
- 1
- Study location
Study Summary
This study will evaluate the safety and effectiveness of taking choline supplements during pregnancy, and whether choline supplementation has an effect on infant development.
Conditions Studied
Interventions
- DIETARY_SUPPLEMENT Placebo
- DRUG Choline
Study Locations (1)
Colorado
- University of Colorado Denver - Aurora
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 351 participants |
| Start Date | 2006-06 |
| Est. Completion | 2017-03 |
| Phase | Phase 1 |
What the finished NCT00332124 record still lists
NCT00332124 is an interventional study that assigns participants to a tested intervention. The registered 351 participants enrollment target is mid-sized for trials with a published cap, below the 871-participant average among 191 other Pregnancy trials with a reported enrollment target (60% lower).
The record links to 2 conditions, with Pregnancy appearing as the primary indexed condition, and to 2 interventions - of which Placebo is the first listed.
NCT00332124 reports a single indexed study location in Colorado.
Frequently Asked Questions
What is clinical trial NCT00332124 about?
NCT00332124 is a clinical study titled "Safety and Effectiveness of Taking Choline Supplements During Pregnancy for Improving Infant Brain Development". This study will evaluate the safety and effectiveness of taking choline supplements during pregnancy, and whether choline supplementation has an effect on infant development.
What is the current status of trial NCT00332124?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 351 participants. The study started on 2006-06. Estimated completion is 2017-03.
What conditions does trial NCT00332124 study?
This clinical trial studies the following conditions: Pregnancy, Child Development.
What interventions are being tested in trial NCT00332124?
The interventions under investigation include: Placebo (DIETARY_SUPPLEMENT), Choline (DRUG).
Who is sponsoring clinical trial NCT00332124?
This trial is sponsored by University of Colorado, Denver, which has 1,283 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00332124 being conducted?
This trial has 1 study location across Colorado. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Pregnancy
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT00332124's enrollment target sits among peer trials
351 64th of 191 higher than 128 of 191 other Pregnancy trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Pregnancy trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Parents Matter!: Interventions to Promote Effective Parent-Child Communication
COMPLETED · Phase 1
-
A Study to Evaluate the Safety and Tolerance of Stavudine (d4T) in Combination With Lamivudine (3TC) in HIV-Positive Pregnant Women and Their Infants
COMPLETED · Phase 1
-
Study to Evaluate Suppression of Ovulation and Pharmacokinetics of Medroxyprogesterone Acetate Following Administration of TV-46046 in Women With Ovulatory Cycle
COMPLETED · Phase 1
-
Pharmacokinetic Study of Makena® (Hydroxyprogesterone Caproate Injection, 250 mg/mL) and Its Metabolites in Blood
COMPLETED · Phase 1
-
A Study to Evaluate the Safety and Tolerance of Combination Anti-HIV Drug Therapy (Indinavir, Lamivudine, and Zidovudine) in HIV-Positive Pregnant Women and Their Infants
COMPLETED · Phase 1
-
Stelara and Tremfya Pregnancy Exposure Registry OTIS Autoimmune Diseases in Pregnancy Project
RECRUITING
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT06241456 · 351 participants · Phase 1
FT825/ONO-8250, an Off-the-Shelf, HER2 CAR-T, With or Without Monoclonal Antibodies in Advanced Solid Tumors
- NCT06576726 · 351 participants
Sensorimotor and Psychosocial Trajectories in Adolescents With Tic Disorder
- NCT07043400 · 351 participants · Phase 3
A Study to Investigate Tislelizumab Administered as Subcutaneous Injection Versus Intravenous Infusion Plus Chemotherapy in Patients With Unresectable or Metastatic Gastric or Gastroesophageal Junction Adenocarcinoma
- NCT07261423 · 351 participants · NA
Pollution Intervention to Impact Kids Asthma Study
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia